Download original image
Fig. 1. (A) Rotarod test. (B) Limb placement test. G19, G16, G5 hUCB-MSC-treated rats showed an improved functional behavioral outcome compared to the control group. (C) Infarct size. Reduced infarct size in MCAO rats that received hUCB-MSCs. (D) Representative cresyl violet staining images revealed that the ischemic site in rats that received hUCB-MSCs after MCAO was significantly smaller than that in rats in the PBS group. Scale bar=1000 µm. Data are expressed as the mean percentage of the infarct size±SEM (*p<0.05 experimental vs. control group) relative to the size of the intact hemisphere.
Exp Neurobiol 2015;24:358~365
© Exp Neurobiol